2m 2m 2m 2m 2m 2m 2m
INHIBIKASE THRP (IKT)
NASDAQ
$1.58-$0.05 (-3.01%)
Price as of Nov 12, 2026 8:52 AM EST- $227.4MMarket Cap
- 0.62%1-Year Change
- BiotechnologyIndustry
INHIBIKASE THRP (IKT)
$1.58-$0.05 (-3.01%)
IKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.63 | ||
Change | +$0.08 (+5.16%) | ||
Open | $1.56 | ||
High | $1.66 | ||
Low | $1.55 | ||
Previous Close | $1.55 | ||
Volume | 413,431 | ||
30-Day Average Volume | 685,077 | ||
1-Week Change | 4.15% | ||
1-Month Change | -17.26% | ||
1-Year Change | 0.62% | ||
3-Year Change | 63.00% | ||
5-Year Change | -86.62% | ||
Fundamentals | |||
Shares Outstanding | 139.5M | ||
Total Assets | $201.8M | ||
Market Cap | $227.4M | ||
Enterprise Value | $175.7M | ||
Period: QTR TTM FY | |||
Revenue | $1.8M | ||
Net Income | -$20.5M | ||
Free Cash Flow | -$17.4M | ||
EBIT | -$20.5M | ||
EBITDA | -$20.5M | ||
Net Working Capital | $185.8M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 100 | ||
P/B | 1 | ||
P/E | -16 | ||
PEG | -2 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/30/2023 | ||
Earnings & Revenue